THE EFFICACY OF CEDIRANIB AS MONOTHERAPY AND IN COMBINATION WITH LOMUSTINE COMPARED TO LOMUSTINE ALONE IN PATIENTS WITH RECURRENT GLIOBLASTOMA: A PHASE III RANDOMIZED STUDY

被引：0

作者：

Batchelor, Tracy ^{[1
]}

Mulholland, Paul ^{[2
]}

Neyns, Bart ^{[3
]}

Nabors, L. B. ^{[4
]}

Campone, Mario ^{[5
]}

Wick, Antje ^{[6
]}

Mason, Warren ^{[7
]}

Mikkelsen, Tom ^{[8
]}

Phuphanich, Surasek ^{[9
]}

Ashby, Lynn S. ^{[10
]}

DeGroot, John F. ^{[11
]}

Gattamancni, H. R. ^{[12
]}

Cher, Lawrence M.

Rosenthal, Mark A. ^{[13
]}

Payer, Franz ^{[14
]}

Xu, John ^{[15
]}

Liu, Qi ^{[15
]}

van den Bent, Martin ^{[16
]}

机构：

[1] Massachusetts Gen Hosp, Boston, MA 02114 USA

[2] UCL, London, England

[3] Univ Ziekenhuis Brussel, Brussels, Belgium

[4] Univ Alabama, Neurooncol Program, Birmingham, AL USA

[5] Ctr Rene Gauducheau, St Herblain, France

[6] Univ Heidelberg, D-6900 Heidelberg, Germany

[7] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada

[8] Henry Ford Hosp, Detroit, MI 48202 USA

[9] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA

[10] Barrow Neurol Inst, Phoenix, AZ 85013 USA

[11] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[12] Christie Fdn Trust Hosp, Manchester, Lancs, England

[13] Royal Melbourne Hosp, Melbourne, Vic, Australia

[14] Med Univ Graz, Graz, Austria

[15] AstraZeneca, Wilmington, NC USA

[16] Erasmus Univ Hosp, Daniel den Hoed Canc Ctr, Rotterdam, Netherlands

来源：

NEURO-ONCOLOGY | 2010年 / 12卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：75 / 75

页数：1

共 50 条

[1] A PHASE III RANDOMIZED STUDY COMPARING THE EFFICACY OF CEDIRANIB AS MONOTHERAPY, AND IN COMBINATION WITH LOMUSTINE, WITH LOMUSTINE ALONE IN RECURRENT GLIOBLASTOMA PATIENTS
Batchelor, T.
Mulholland, P.
Neyns, B.
Nabors, L. B.
Campone, M.
Wick, A.
Mason, W.
Xu, J.
Liu, Q.
van den Bent, M.
[J]. ANNALS OF ONCOLOGY, 2010, 21 : 4 - 4
[2] Phase III Randomized Trial Comparing the Efficacy of Cediranib As Monotherapy, and in Combination With Lomustine, Versus Lomustine Alone in Patients With Recurrent Glioblastoma
Batchelor, Tracy T.
Mulholland, Paul
Neyns, Bart
Nabors, L. Burt
Campone, Mario
Wick, Antje
Mason, Warren
Mikkelsen, Tom
Phuphanich, Surasak
Ashby, Lynn S.
DeGroot, John
Gattamaneni, Rao
Cher, Lawrence
Rosenthal, Mark
Payer, Franz
Juergensmeier, Juliane M.
Jain, Rakesh K.
Sorensen, A. Gregory
Xu, John
Liu, Qi
van den Bent, Martin
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26) : 3212 - 3218
[3] A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma
Brandes, Alba A.
Carpentier, Antoine F.
Kesari, Santosh
Sepulveda-Sanchez, Juan M.
Wheeler, Helen R.
Chinot, Olivier
Cher, Lawrence
Steinbach, Joachim P.
Capper, David
Specenier, Pol
Rodon, Jordi
Cleverly, Ann
Smith, Claire
Gueorguieva, Ivelina
Miles, Colin
Guba, Susan C.
Desaiah, Durisala
Lahn, Michael M.
Wick, Wolfgang
[J]. NEURO-ONCOLOGY, 2016, 18 (08) : 1146 - 1156
[4] A phase II study of galunisertib monotherapy or galunisertib plus lomustine compared to lomustine monotherapy in recurrent glioblastoma
Brandes, Alba Ariela
Carpentier, Antoine F.
Kesari, Santosh
Sepulveda, Juan
Wheeler, Helen
Chinot, Olivier L.
Cher, Lawrence
Steinbach, Joachim Peter
Specenier, Pol
Cleverly, Ann
Smith, Claire
Gueorguieva, Ivelina
Guba, Susan C.
Desaiah, Durisala
Lahn, Michael M. F.
Wick, Wolfgang
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[5] Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma
Wick, Wolfgang
Puduvalli, Vinay K.
Chamberlain, Marc C.
van den Bent, Martin J.
Carpentier, Antoine F.
Cher, Lawrence M.
Mason, Warren
Weller, Michael
Hong, Shengyan
Musib, Luna
Liepa, Astra M.
Thornton, Donald E.
Fine, Howard A.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (07) : 1168 - 1174
[6] Randomized phase II study of axitinib alone or combined with lomustine in patients with recurrent glioblastoma.
Duerinck, Johnny
Du Four, Stephanie
Bouttens, Frank
Verschaeve, Vincent
Andre, Chantal
Van Fraeyenhove, Frank
Chaskis, Cristo
D'Haene, Nicky
Le Mercier, Marie
Salmon, Isabelle
Neyns, Bart
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[7] Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma
Duerinck, J.
Du Four, S.
Bouttens, F.
Andre, C.
Verschaeve, V.
Van Fraeyenhove, F.
Chaskis, C.
D'Haene, N.
Le Mercier, M.
Rogiers, A.
Michotte, A.
Salmon, I.
Neyns, B.
[J]. JOURNAL OF NEURO-ONCOLOGY, 2018, 136 (01) : 115 - 125
[8] Randomized phase II trial comparing axitinib with the combination of axitinib and lomustine in patients with recurrent glioblastoma
J. Duerinck
S. Du Four
F. Bouttens
C. Andre
V. Verschaeve
F. Van Fraeyenhove
C. Chaskis
N. D’Haene
M. Le Mercier
A. Rogiers
A. Michotte
I. Salmon
B. Neyns
[J]. Journal of Neuro-Oncology, 2018, 136 : 115 - 125
[9] A PHASE I, OPEN LABEL, MULTICENTER STUDY TO ASSESS THE SAFETY AND TOLERABILITY OF CEDIRANIB (RECENTINTM) IN COMBINATION WITH LOMUSTINE CHEMOTHERAPY FOR PATIENTS WITH RECURRENT GLIOBLASTOMA
Batchelor, T. T.
de Bono, J. S.
Wen, P. Y.
Drappatz, J.
Plotkin, S. R.
Hochberg, F. H.
Chi, A. S.
Harris, D.
Barriuso, J.
Frentzas, S.
Robertson, J.
Xu, Q.
Liu, Q.
[J]. NEURO-ONCOLOGY, 2009, 11 (06) : 905 - 905
[10] Toxicity and efficacy of lomustine and bevacizumab in recurrent glioblastoma patients
Jakobsen, J. N.
Urup, T.
Grunnet, K.
Toft, A.
Johansen, M. D.
Poulsen, S. H.
Christensen, I. J.
Muhic, A.
Poulsen, H. S.
[J]. JOURNAL OF NEURO-ONCOLOGY, 2018, 137 (02) : 439 - 446

← 1 2 3 4 5 →